Skip to content

MENS - Jyong Biotech Ltd. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

Jyong Biotech Ltd. Ordinary Shares

MENS · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MENSJyong Biotech Ltd. Ordinary Shares

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $67.00
52-wk low: $1.43
Prev close: $31.58
Mkt cap: $158.1M
Profit margin: +0.0%
Op margin: +0.0%

Smart money

4 funds hold a position.

Real smart money

Funds holding this stock

4 holders

Combined position$654K

MG
Man Group
Q4 2025 13F
$56K
position
JS
Jim Simons
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $158M

Valuation

Quality

Operating margin0.0%
ROE0.0%
ROA

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MENS
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $158.14M

Analysts

What do analysts expect?

No data yet

No analyst coverage yet for this stock.

We show it when enough analysts cover the stock.

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

ROE

+0.0%

$47K

position

BR

BlackRock

Q2 2026 13F

$539K

position

1 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 1 holders

Coverage gaps for MENS

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

-12.0%

Growth